BRPI0413469A - derivados de piperazina para o tratamento de infecções por hiv - Google Patents

derivados de piperazina para o tratamento de infecções por hiv

Info

Publication number: BRPI0413469A
Authority: BR; Brazil
Prior art keywords: treatment; derivatives; hiv; piperazine derivatives; hiv infections
Prior art date: 2003-08-14

Application number

BRPI0413469-9A

Other languages

English (en)

Portuguese (pt)

Inventor

Donald Stuart Middleton

Charles Eric Mowbray

Peter Thomas Stephenson

David Howard Williams

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-08-14

Filing date

2004-08-04

Publication date

2006-10-17

2003-08-14 Priority claimed from GB0319149A external-priority patent/GB0319149D0/en

2003-09-22 Priority claimed from GB0322153A external-priority patent/GB0322153D0/en

2004-03-24 Priority claimed from GB0406656A external-priority patent/GB0406656D0/en

2004-08-04 Application filed by Pfizer filed Critical Pfizer

2006-10-17 Publication of BRPI0413469A publication Critical patent/BRPI0413469A/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Manufacturing & Machinery (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Ceramic Engineering (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Materials Engineering (AREA)
Structural Engineering (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0413469-9A 2003-08-14 2004-08-04 derivados de piperazina para o tratamento de infecções por hiv BRPI0413469A (pt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0319149A GB0319149D0 (en)	2003-08-14	2003-08-14	Chemical compounds
GB0322153A GB0322153D0 (en)	2003-09-22	2003-09-22	Chemical compounds
GB0406656A GB0406656D0 (en)	2004-03-24	2004-03-24	Chemical compounds
PCT/IB2004/002562 WO2005016344A1 (en)	2003-08-14	2004-08-04	Piperazine derivatives for the treatment of hiv infections

Publications (1)

Publication Number	Publication Date
BRPI0413469A true BRPI0413469A (pt)	2006-10-17

Family

ID=34198586

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0413469-9A BRPI0413469A (pt)	2003-08-14	2004-08-04	derivados de piperazina para o tratamento de infecções por hiv

Country Status (23)

Country	Link
EP (1)	EP1663234A1 (xx)
JP (1)	JP2007502266A (xx)
KR (1)	KR20060037442A (xx)
AP (1)	AP2006003514A0 (xx)
AR (1)	AR045931A1 (xx)
AU (1)	AU2004264724A1 (xx)
BR (1)	BRPI0413469A (xx)
CA (1)	CA2534866A1 (xx)
EA (1)	EA200600225A1 (xx)
EC (1)	ECSP066361A (xx)
IL (1)	IL173365A0 (xx)
IS (1)	IS8275A (xx)
MA (1)	MA27990A1 (xx)
MX (1)	MXPA06001762A (xx)
NL (1)	NL1026827C2 (xx)
NO (1)	NO20061170L (xx)
OA (1)	OA13235A (xx)
PA (1)	PA8608901A1 (xx)
PE (1)	PE20050867A1 (xx)
TN (1)	TNSN06051A1 (xx)
TW (1)	TW200512208A (xx)
UY (1)	UY28466A1 (xx)
WO (1)	WO2005016344A1 (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI329105B (en)	2002-02-01	2010-08-21	Rigel Pharmaceuticals Inc	2,4-pyrimidinediamine compounds and their uses
KR20120062863A (ko)	2003-07-30	2012-06-14	리겔 파마슈티칼스, 인크.	자가면역 질환의 치료 또는 예방에 사용하기 위한 2,4-피리미딘디아민 화합물
US20060100432A1 (en)	2004-11-09	2006-05-11	Matiskella John D	Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
FR2880887B1 (fr) *	2005-01-14	2009-01-30	Merck Sante Soc Par Actions Si	Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
WO2006085199A1 (en) *	2005-02-14	2006-08-17	Pfizer Limited	Piperazine derivatives
WO2006133426A2 (en)	2005-06-08	2006-12-14	Rigel Pharmaceuticals, Inc.	Compositions and methods for inhibition of the jak pathway
US20070203161A1 (en)	2006-02-24	2007-08-30	Rigel Pharmaceuticals, Inc.	Compositions and methods for inhibition of the jak pathway
US7396830B2 (en)	2005-10-04	2008-07-08	Bristol-Myers Squibb Company	Piperazine amidines as antiviral agents
US7851476B2 (en)	2005-12-14	2010-12-14	Bristol-Myers Squibb Company	Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US8962643B2 (en)	2006-02-24	2015-02-24	Rigel Pharmaceuticals, Inc.	Compositions and methods for inhibition of the JAK pathway
US7501419B2 (en)	2006-04-25	2009-03-10	Bristol-Myers Squibb Company	4-Squarylpiperazine derivatives as antiviral agents
US7807671B2 (en)	2006-04-25	2010-10-05	Bristol-Myers Squibb Company	Diketo-piperazine and piperidine derivatives as antiviral agents
US7572810B2 (en)	2006-06-08	2009-08-11	Bristol-Myers Squibb Company	Alkene piperidine derivatives as antiviral agents
US7504399B2 (en)	2006-06-08	2009-03-17	Bristol-Meyers Squibb Company	Piperazine enamines as antiviral agents
NZ587589A (en)	2008-02-15	2012-10-26	Rigel Pharmaceuticals Inc	Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
PT2323993E (pt)	2008-04-16	2015-10-12	Portola Pharm Inc	2,6-diamino-pirimidina-5-il-carboxamidas como inibidores de quinasses syk ou jak
US8138339B2 (en)	2008-04-16	2012-03-20	Portola Pharmaceuticals, Inc.	Inhibitors of protein kinases
CN103224497A (zh)	2008-04-22	2013-07-31	波托拉医药品公司	蛋白激酶抑制剂
JP5433690B2 (ja)	2008-06-25	2014-03-05	ブリストル−マイヤーズスクイブカンパニー	抗−ｈｉｖ薬としてのジケト縮合アゾロピペリジンおよびアゾロピペラジン
US8242124B2 (en)	2008-06-25	2012-08-14	Bristol-Myers Squibb Company	Diketopiperidine derivatives as HIV attachment inhibitors
US8450361B2 (en)	2010-08-06	2013-05-28	Bristol-Myers Squibb Company	Substituted indole and azaindole oxoacetyl piperazinamide derivatives
US9102625B2 (en)	2010-11-01	2015-08-11	Portola Pharmaceuticals, Inc.	Nicotinamides as JAK kinase modulators
WO2012075235A1 (en)	2010-12-02	2012-06-07	Bristol-Myers Squibb Company	Alkyl amides as hiv attachment inhibitors
EP2696937B1 (en)	2011-04-12	2017-05-17	VIIV Healthcare UK (No.5) Limited	Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors
ES2609579T3 (es)	2011-08-29	2017-04-21	VIIV Healthcare UK (No.5) Limited	Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH
US8835454B2 (en)	2011-08-29	2014-09-16	Bristol-Myers Squibb Company	Fused bicyclic diamine derivatives as HIV attachment inhibitors
AU2012340555B2 (en)	2011-11-23	2016-10-20	Portola Pharmaceuticals, Inc.	Pyrazine kinase inhibitors
WO2013138436A1 (en)	2012-03-14	2013-09-19	Bristol-Myers Squibb Company	Cyclolic hydrazine derivatives as hiv attachment inhibitors
WO2014025852A1 (en)	2012-08-09	2014-02-13	Bristol-Myers Squibb Company	Tricyclic alkene derivatives as hiv attachment inhibitors
EP2895471B1 (en)	2012-08-09	2016-11-23	VIIV Healthcare UK (No.5) Limited	Piperidine amide derivatives as hiv attachment inhibitors
WO2014058921A2 (en)	2012-10-08	2014-04-17	Portola Pharmaceuticals, Inc.	Substituted pyrimidinyl kinase inhibitors
PT2968316T (pt)	2013-03-13	2019-10-29	Forma Therapeutics Inc	Derivados de 2-hidroxi-1-{4-[(4-fenilfenil)carbonil]piperazin-1-il}etano-1-ona e compostos relacionados como inibidores da sintase de ácidos gordos (fasn) para o tratamento do cancro
US10035799B2 (en)	2015-01-30	2018-07-31	Lieber Institute For Brain Development	COMT inhibiting methods and compositions
US10934283B2 (en)	2015-11-25	2021-03-02	Lieber Institute, Inc.	COMT inhibiting methods and compositions
TWI767148B (zh)	2018-10-10	2022-06-11	美商弗瑪治療公司	抑制脂肪酸合成酶(fasn)
CN113382633A (zh)	2018-10-29	2021-09-10	福马治疗股份有限公司	(4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR1397193A (fr) *	1963-12-06	1965-04-30	Lepetit Spa	Procédé de préparation de nouveaux dérivés de la pipérazine
US3865828A (en) *	1972-03-22	1975-02-11	Egyt Gyogyszervegyeszeti Gyar	Pyridine derivatives having antidepressant activity
JPS5139039A (ja) *	1974-09-28	1976-04-01	Mitsubishi Paper Mills Ltd	Karaayokankozairyo
EA006079B1 (ru) *	2000-03-31	2005-08-25	Пфайзер Продактс Инк.	Новые пиперазиновые производные
US6573262B2 (en) *	2000-07-10	2003-06-03	Bristol-Myers Sqibb Company	Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
US6825201B2 (en) *	2001-04-25	2004-11-30	Bristol-Myers Squibb Company	Indole, azaindole and related heterocyclic amidopiperazine derivatives

2004
- 2004-08-04 AU AU2004264724A patent/AU2004264724A1/en not_active Abandoned
- 2004-08-04 EP EP04744202A patent/EP1663234A1/en not_active Withdrawn
- 2004-08-04 CA CA002534866A patent/CA2534866A1/en not_active Abandoned
- 2004-08-04 OA OA1200600049A patent/OA13235A/en unknown
- 2004-08-04 WO PCT/IB2004/002562 patent/WO2005016344A1/en not_active Application Discontinuation
- 2004-08-04 KR KR1020067003015A patent/KR20060037442A/ko not_active Application Discontinuation
- 2004-08-04 JP JP2006523071A patent/JP2007502266A/ja active Pending
- 2004-08-04 EA EA200600225A patent/EA200600225A1/ru unknown
- 2004-08-04 MX MXPA06001762A patent/MXPA06001762A/es not_active Application Discontinuation
- 2004-08-04 AP AP2006003514A patent/AP2006003514A0/xx unknown
- 2004-08-04 BR BRPI0413469-9A patent/BRPI0413469A/pt not_active IP Right Cessation
- 2004-08-10 PE PE2004000779A patent/PE20050867A1/es not_active Application Discontinuation
- 2004-08-11 TW TW093124083A patent/TW200512208A/zh unknown
- 2004-08-12 PA PA20048608901A patent/PA8608901A1/es unknown
- 2004-08-12 NL NL1026827A patent/NL1026827C2/nl not_active IP Right Cessation
- 2004-08-12 UY UY28466A patent/UY28466A1/es not_active Application Discontinuation
- 2004-08-12 AR ARP040102888A patent/AR045931A1/es unknown
2006
- 2006-01-25 IL IL173365A patent/IL173365A0/en unknown
- 2006-01-31 IS IS8275A patent/IS8275A/is unknown
- 2006-02-13 EC EC2006006361A patent/ECSP066361A/es unknown
- 2006-02-14 TN TNP2006000051A patent/TNSN06051A1/fr unknown
- 2006-02-14 MA MA28803A patent/MA27990A1/fr unknown
- 2006-03-13 NO NO20061170A patent/NO20061170L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2534866A1 (en)	2005-02-24
NL1026827A1 (nl)	2005-03-09
PA8608901A1 (es)	2005-03-03
AR045931A1 (es)	2005-11-16
AU2004264724A1 (en)	2005-02-24
WO2005016344A1 (en)	2005-02-24
JP2007502266A (ja)	2007-02-08
EP1663234A1 (en)	2006-06-07
IL173365A0 (en)	2006-06-11
ECSP066361A (es)	2006-08-30
IS8275A (is)	2006-01-31
PE20050867A1 (es)	2005-11-10
MXPA06001762A (es)	2006-05-12
OA13235A (en)	2006-12-13
AP2006003514A0 (en)	2006-02-28
MA27990A1 (fr)	2006-07-03
TNSN06051A1 (fr)	2007-10-03
TW200512208A (en)	2005-04-01
UY28466A1 (es)	2005-03-31
EA200600225A1 (ru)	2006-08-25
KR20060037442A (ko)	2006-05-03
NO20061170L (no)	2006-05-15
NL1026827C2 (nl)	2005-11-23

Legal Events

Date	Code	Title	Description
2012-05-22	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.
2012-10-16	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.

Publication	Publication Date	Title
BRPI0413469A (pt)	2006-10-17	derivados de piperazina para o tratamento de infecções por hiv
BR0316081A (pt)	2005-09-27	Derivados de 2-piridona como inibidores de elastase de neutrófilo
BR0209267A (pt)	2004-06-15	Pirimidinas fundidas como antagonistas do fator de liberação de corticotropina (crf)
BRPI0417458A (pt)	2007-03-13	compostos inibidores de dpp-iv, sais faramaceuticamente aceitáveis e pró-fármacos do mesmo, seus processos de preparação, composição farmacêutica compreendendo os mesmos e uso dos referidos compostos na fabricação de medicamento
BR0208811A (pt)	2004-03-09	Derivados de pirazol para tratamento de hiv
BR0309012A (pt)	2005-02-01	Uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para a preparação de um composto
BR0111263A (pt)	2003-06-17	Derivados de 2-aminocarbonil-9h-purina
BRPI0510319A (pt)	2007-10-16	inibidores da enzima integrase de hiv
BRPI0414570A (pt)	2006-11-07	derivados de 2-piridona como inibidores de elastase de neutrófilo e seu uso
BR0213522A (pt)	2004-09-08	Composto, composição farmacêutica, métodos de inibir a hiv integrase e para prevenir ou tratar a infecção pelo hiv ou para prevenir, tratar ou retardar o inìcio da aids em um paciente, e, combinação útil para tratar ou prevenir a infecção pelo hiv ou para prevenir, tratar ou retardar o inìcio da aids
BR0108893A (pt)	2002-11-05	Composição farmacêutica, composto e processo de preparação de compostos
BRPI0408767A (pt)	2006-03-28	inibidores de transcriptase reversa não-nucleosìdeos i para o tratamento de doenças mediadas pelo hiv
BR0015056A (pt)	2003-06-10	Composto, uso de um composto, composição farmacêutica, método de tratamento de infecções por hiv e kit farmacêutico
BR0316771A (pt)	2005-10-25	Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica
BR0212069A (pt)	2004-07-20	Agentes antidiabéticos orais
BRPI0607214B8 (pt)	2021-05-25	derivados de 2-(4-cianofenilamino)pirimidina inibidores de hiv, composição farmacêutica que os compreende e seus processos de preparação
BR0113590A (pt)	2003-07-22	7-oxo-piridopirimidinas
BR9912142A (pt)	2001-10-30	6-benzil-4-oxipirimidinas substituìdas, processopara sua preparação e composições contendo-as
ATE473212T1 (de)	2010-07-15	Hiv-inhibierende 2-(4-cyanophenyl)-6- hydroxylaminopyrimidine
BR0308786A (pt)	2005-01-11	Derivados de ftalimido como inibidores da monoamina oxidase b
BR0306927A (pt)	2004-11-09	Compostos tricìclicos de 2-pirimidona úteis como inibidores de transcriptase reversa de hiv
BR0314860A (pt)	2005-08-02	Derivados de pirazol
BRPI0606997A2 (pt)	2009-07-28	compostos, processo para a sua manufatura, composições farmacêuticas que os contêm, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas ppar(delta) e/ou ppar(alfa) e utilização dos compostos
BR0308807A (pt)	2005-01-04	Compostos tiazol-2-il-imina como inibidores de pde-7
BR0300698A (pt)	2004-09-08	Compostos derivados de quinazolina, um processo para sua preparação e composições farmacêuticas contendo-os